Harvard Bioscience Inc (HBIO): Long-Term Debt
$35.87M
As of 2025-12-31
$36.68M
As of 2026-06-30
-8.5%
3-year compound annual growth
-5.7%
5-year compound annual growth
+6.6%
10-year compound annual growth
| Period ended | Long-Term Debt | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $35.87M | -2.9% | 2026-03-13, Balance as of period end |
| 2024-12-31 | $36.96M | +1.1% | 2026-03-13, Balance as of period end |
| 2023-12-31 | $36.56M | -21.9% | 2025-03-14, Balance as of period end |
| 2022-12-31 | $46.82M | -3.1% | 2024-03-07, Balance as of period end |
| 2021-12-31 | $48.33M | +0.7% | 2023-03-09, Balance as of period end |
| 2020-12-31 | $48.01M | -10.8% | 2022-03-11, Balance as of period end |
| 2019-12-31 | $53.82M | -11.5% | 2021-03-17, Balance as of period end |
| 2018-12-31 | $60.80M | +410.9% | 2020-03-16, Balance as of period end |
| 2017-12-31 | $11.90M | -14.1% | 2018-03-16, Balance as of period end |
| 2016-12-31 | $13.85M | -26.7% | 2017-03-17, Balance as of period end |
| 2015-12-31 | $18.90M | -11.9% | 2016-04-29, Balance as of period end |
| 2014-12-31 | $21.45M | -13.3% | 2015-03-12, Balance as of period end |
| 2013-12-31 | $24.75M | +91.1% | 2014-03-14, Balance as of period end |
| 2012-12-31 | $12.95M | n/a | 2013-03-18, Balance as of period end |
Long-Term Debt at similar companies
| Company | Year ended | Long-Term Debt | Change YoY |
|---|---|---|---|
| Harvard Bioscience Inc (HBIO) | 2025-12-31 | $35.87M | -2.9% |
| Precipio, Inc. (PRPO) | 2025-12-31 | $83.0K | -78.3% |
| Bio-Rad Laboratories, Inc. (BIO) | 2025-12-31 | $1.20B | +0.2% |
| Waters Corp (WAT) | 2025-12-31 | $1.41B | -13.5% |
| Bruker Corp (BRKR) | 2025-12-31 | $1.87B | -10.8% |
| Mettler Toledo International Inc (MTD) | 2025-12-31 | $2.09B | +14.0% |
| Avantor, Inc. (AVTR) | 2025-12-31 | $3.95B | -2.7% |
| Agilent Technologies, Inc. (A) | 2025-10-31 | $3.05B | -8.8% |
Compare HBIO, PRPO, BIO, WAT side by side · Screen every company in Laboratory Analytical Instruments ↗